MONOLISA Anti-HAV EIA

Image
bvd_72496_pdp.jpg

Overview

An enzyme immunoassay for the in vitro detection of total antibodies (IgG and IgM) to hepatitis A virus (anti-HAV) in human adult and pediatric serum or plasma
Read full description Ordering Information

Description

Description

MONOLISA Anti-HAV EIA detects total (IgG and IgM) antibodies to hepatitis A virus (HAV) in human (adult or pediatric) serum or plasma. Tests for total anti-HAV antibodies do not discriminate among different antibody classes. The presence of total anti-HAV is a sign of exposure to HAV. It does not distinguish between present and past infection and is therefore useful primarily for epidemiological purposes. The recent availability of anti-HAV vaccines has prompted the development of more sensitive assays, used for screening non-vaccinated individuals, to follow up on antibody response after vaccination, and to estimate the need and timing of booster vaccinations. Specificity in hepatitis testing is critical—trust Bio-Rad’s expertise in immunology and continually updated reagents for all hepatitis testing needs.

Ordering

Ordering

items

Use the filters below to refine results!

Documents

Documents

Number Description Options
P-130
Hepatitis Product Brochure (U.S. Version)
[ Add to Cart (Free) ]